Ilana Keren

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

C. Hoggart, K. To, P. Soler-Palacín, 2023, The Lancet Rheumatology.

Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases

Colin G Fink, L. Coin, L. Coin, 2023, medRxiv.